Recently, Global Pathology Support (GPS) has successfully finished the validation of Provantis 11.0.1 in order to deliver the best service to our clients. This validation was performed with the professional help of the US and UK INSTEM people in line with the requirements set by GPS .

In addition, we now also evaluate Whole Slide Images from preclinical toxicity studies according to Good Laboratory Practice and in line with most recent FDA requirements. Next to conventional histopathology evaluation, we offer this service, for 1-month rodent/non rodent studies, 3-month MTD studies, Carcinogenicity studies, and others.

Moreover, pathology of “Extended One-Generation Reproductive Toxicity Studies (OECD 443)” , including (semi-quantitative) pathology of the reproductive tract and neuropathology, were successfully evaluated in a GLP-Compliant manner.

Histopathology evaluation of digital scans (W.S.I.’s) by the Pathologist (Digital Pathology) is possible following upload of scans (Whole Slide Images) to the “GPS Slide-Suite”. Upload has proven to take about 2 min/slide from either USA, China, or any EU country!

This fully validated method, complies with the GLP-guidelines and is an efficient way, without slide transport, of evaluating slides from preclinical toxicity studies also using the multi-site concept.

Introduction. In the eighties the role of the pathologist within the field of safety assessment of food, chemicals and pharmaceutical products became more and more important. In this period, it was recognized that there was a need for specialized pathologists being trained in pathology, toxicology, pharmacology, laboratory animal science and Good Laboratory Practice. For this reason, in 1988 the Dutch Registration Committee for Laboratory Animal Pathologists/Toxicologic Pathologists (CRP/TP: Commissie Registratie Proefdierpathologen/Toxicologisch Pathologen) was founded. This  Committee falls under the auspices of the Dutch Society of Pathology (NVvP; Nederlandse Vereniging voor Pathologie) and the Royal Dutch Society for Veterinary Medicine (KNMvD; Koninklijke Nederlandse Maatschappij voor Diergeneeskunde) and is responsible for the registration, the re-registration and the training of new laboratory animal pathologists and toxicologic pathologists.

Toxicologic pathology is a very specialized area covering both pathologic and toxicologic subjects. Therefore, in the Netherlands, the training of toxicologic pathologist is a joint responsibility of Veterinary Pathologists (united in a section of the NVvP) and registered Toxicologic Pathologists (united in a section of the Dutch Society of Toxicology; NVT). 

Training of the toxicologic pathologist. Starting from 1989 (after a “de facto” recognition of 18 pathologists working in the field of toxicologic pathology at that time), all newcomers in the field of toxicologic pathology have to follow an extensive training program that is composed, approved and controlled by the CRP/TP. The candidate should be academically educated, preferably as a veterinarian, but medical doctors, or medical biologists may be accepted as trainee based on their pathology- and/or toxicology-related knowledge and experience. The training program comprises at least 4 years and consists partly of courses, but the major part consists of on-the job-training supervised by an experienced Board Certified Toxicologic Pathologist. The training program is additionally monitored by an external tutor. After successful completion of the training program, the candidate will be accredited and registered as Board Certified Toxicologic Pathologist (‘CRP/TP Board Certified Toxicologic Pathologist’). A re-registration procedure every 5 years warrants active participation and abiding proficiency of the registered toxicologic pathologist within his/her profession.

As a Board Certified Toxicologic Pathologist, in about 30 years now, Dr. Thoolen worked (for EU, USA, including China) on many preclinical (sub-) chronic toxicity and carcinogenicity studies which are valid for registration world-wide (see “studies track record”). These studies are valid for all 38 OECD-countries including FDA ( according to the Mutual Acceptance of Data (MAD) Decision).

Dr. Thoolen received is first registration in 1993, and the latest re-registration as Board Certified Toxicologic Pathologist (CRP/TP) was in 2022 (2022-2027).

Digital Pathology, also referred to as Telepathology and Whole Slide Imaging (W.S.I.), is the process of producing high resolution digital images from tissue sections on glass slides, and subsequent evaluation. These glass slides are normally examined under a microscope by a pathologist as part of the diagnostic process. The emergence of digital pathology now means that digital images are stored on secure servers and can be viewed on computer monitors; enabling pathologists to work remotely and to collaborate with other colleagues and/or when second opinions are needed.

Conventional Histopathology

Histopathology is conventionally performed by certified pathologists using a light microscope. This histopathological examination is not an exercise in “picture matching” for it represents a careful step by step evaluation of tissue and cellular patterns. This includes assessment of size, shape, staining characteristics and topographical tissue and cell organizations and integration into meaningful biological conclusions, with considerations of the overall macroscopic and microscopic pathology as well as other related medical disciplines. Species specificity, anatomy, artefacts, control references and experience of the study pathologist are considered key factors in this process. Additional semi-quantitative techniques and artificial intelligence (A.I.) can also be valuable additional techniques for research purposes and decision support.

Digital Pathology: the future of diagnostics

We have been following the developments of Digital Pathology over the recent years, and it seemed good for peer review and/or educational purpose (e.g. Academic Hospitals, large CROs) of limited number of slides, and long-distance tele-communication. In the past, next to conventional light microscopy, also peer review was done faster in a conventional way by reviewing the glass slides. In addition, in the past there were sometimes problems with proper scanning of every slide which was time consuming.

Nowadays, however, the quality of images generated by using Digital Pathology is as good as conventional review of slides for all organ systems using digital pathology. The UMCU Academic hospital in Utrecht, The Netherlands was one of the the first hospitals world-wide going fully digital in pathology with a future-proof complete digital archive (2015).

During and after this time, scan speed, resolution and quality of scans from glass slides (W.S.I.) have been markedly improved. In recent years, substantial increased amount of W.S.I. validation literature is published on this subject. For both in clinical pathology (human) and pre-clinical veterinary pathology practices, things have improved significantly with demonstration of excellent diagnostic concordance between W.S.I. and conventional microscopy. Nowadays, the application of Digital Pathology, when well performed, can match equally with conventional light microscopy in toxicologic pathology for the safety evaluation in toxicology studies in the development of new vaccines, medicines and chemicals.

全球病理学支持中心（GPS）的数字病理学

Global Pathology Support 一直秉承着协助客户实现其发展目标的理念和宗旨。为此我们不断优化服务。目前，除了传统的使用光学显微镜的组织病理学之外，我们还引进了具有创新性的数字病理学。同时我们的数字病理学设备和评估也是经（GLP）认证和认可的。目前数字病理学的优势是：可以在全球范围内对临床前毒理学研究的完整组织病理学进行评估，并且能做到同时提供同行评审解决方案。数字病理学可以通过扫描设备对大量不同格式的图像进行玻片数据信息采集。以下各类扫描仪：（滨松、3DHistech、奥林巴斯Aperio/徕卡、Ventana/Roche、飞利浦、蔡司等都适用）。

For more information: bob.thoolen@gpstoxpath. +31 (0)70 3142404

Bibliography

1. Abels E, Pantanowitz L, Aeffner F, et al. Computational pathology definitions, best practices, and recommendations for regulatory guidance: a white paper from the Digital Pathology Association. The Journal of Pathology 2019;249(3):286-294.
2. Aeffner F, Sing T, Turner OC. Special Issue on Digital Pathology, Tissue Image Analysis, Artificial Intelligence, and Machine Learning: Approximation of the Effect of Novel Technologies on Toxicologic Pathology. Toxicol Pathol 2021;49(4):705-708.
3. Al-Janabi S, Horstman A, van Slooten H-J, et al. Validity of whole slide images for scoring HER2 chromogenic in situ hybridisation in breast cancer. J Clin Pathol 2016;69(11):992. (
4. Al-Janabi S, Huisman A, Jonges GN, et al. Whole slide images for primary diagnostics of urinary system pathology: a feasibility study. J Ren Inj Prev 2014;3(4):91-96.
5. Araújo ALD, do Amaral-Silva GK, Pérez-de-Oliveira ME, et al. Fully digital pathology laboratory routine and remote reporting of oral and maxillofacial diagnosis during the COVID-19 pandemic: a validation study. Virchows Archiv : an international journal of pathology 2021;479(3):585-595.
6. Azam AS, Miligy IM, Kimani PK-U, et al. Diagnostic concordance and discordance in digital pathology: a systematic review and meta-analysis. J Clin Pathol 2021;74(7):448-455.
7. Baidoshvili A, Stathonikos N., Freling G, et al. Validation of a whole-slide image-based teleconsultation network. Histopathology 2018;73(5):777-783.
8. Baidoshvili A, Bucur A, van Leeuwen J, et al. Evaluating the benefits of digital pathology implementation: time savings in laboratory logistics. Histopathology 2018;73(5):784-794.
9. Bejnordi BE, Balkenhol M, Litjens G, et al. Automated Detection of DCIS in Whole-Slide H&E Stained Breast Histopathology Images. IEEE Trans Med Imaging 2016;35(9):2141-2150.
10. Bejnordi BE, Karssemeijer N, Timofeeva N, et al. Quantitative analysis of stain variability in histology slides and an algorithm for standardization. Prog. Biomed. Opt. Imaging – Proc. SPIE 2014;9041:7.
11. Bejnordi BE, Litjens G, Hermsen M, et al. A multi-scale superpixel classification approach to the detection of regions of interest in whole slide histopathology images.  Proc. SPIE, Med Imag 2015:6.
12. Bertram CA, Firsching T, Klopfleisch R. Virtual microscopy in histopathology training: Changing student attitudes in 3 successive academic years. Journal of Veterinary Medical Education 2018;45(2):241-249.
13. Bertram CA, Stathonikos N, Donovan TA, et al. Validation of digital microscopy: Review of validation methods and sources of bias. Vet Pathol 2022;59(1):26-38.
14. Betmouni S. Diagnostic digital pathology implementation: Learning from the digital health experience. Digit Health 2021;7.
15. Bongaerts O, Clevers C, Debets M, et al. Conventional Microscopical versus Digital Whole-Slide Imaging-Based Diagnosis of Thin-Layer Cervical Specimens: A Validation Study. J Pathol Inform 2018;9:29.
16. Borowsky AD, Bishop JW, Darrow MA, et al. Digital whole slide imaging compared with light microscopy for primary diagnosis in surgical pathology: A multicenter, double-blinded, randomized study of 2045 cases. Arch Pathol Lab Med 2020;144(10):1245-1253.
17. Caputo A, D’Antonio A. Digital pathology: the future is now. Ind J Pathol Microbiol 2021;64(1):6-7.
18. Cimadamore A, Scarpelli M, Montironi R, et al. Digital pathology and COVID-19 and future crises: pathologists can safely diagnose cases from home using a consumer monitor and a mini PC. J Clin Pathol 2020;73(11):695-696.
19. Clarke E, Doherty D, Randell R, et al. Faster than light (microscopy): superiority of digital pathology over microscopy for assessment of immunohistochemistry. J Clin Pathol 2022;0:1-6.
20. Evans AJ, Brown RW, Bui MM, et al. Validating Whole Slide Imaging Systems for Diagnostic Purposes in Pathology. Arch Pathol Lab Med 2022;146(4):440-450.
21. FDA. The US Food and Drug Administration temporarily relaxes regulations around digital pathology to facilitate remote reviewing of digital pathology slides during the COVID-19 pandemic. globenewswire 2020.
22. Forest T, Aeffner F, Bangari DS, et al. Scientific and Regulatory Policy Committee Brief Communication: 2019 Survey on Use of Digital Histopathology Systems in Nonclinical Toxicology Studies. Toxicol Pathol 2022;50(3):397-401.
23. Geijs DJ, Intezar M, van der Laak JAWM, et al. Medical Imaging: Digital Pathology – Automatic color unmixing of IHC stained whole slide images.  Med Imag 2018: Dig Pathol 2018:165-171.
24. Ghezloo F, Pin-Chieh W, Kerr KF, et al. An analysis of pathologists viewing processes as they diagnose whole slide digital images. J Pathol Inf 2022;13:1-6.
25. Go H. Digital Pathology and Artificial Intelligence Applications in Pathology. Brain Tumor Res Treat 2022;10(2):76-82.
26. Hanna MG, Ardon O, Reuter VE, et al. Integrating digital pathology into clinical practice. Mod Pathol 2021;35(2):152-164.
27. Hanna MG, Reuter VE, Ardon O, et al. Validation of a digital pathology system including remote review during the COVID-19 pandemic. Mod Pathol 2020;33(11):2115-2127.
28. Jacobsen M, Lewis A, Baily J, et al. Utilizing Whole Slide Images for the Primary Evaluation and Peer Review of a GLP-Compliant Rodent Toxicology Study. Toxicol Pathol 2021;49(6):1164-1173.
29. Jahn SW, Plass M, Moinfar F, et al. Digital pathology: Advantages, limitations and emerging perspectives. J Clin Med 2020;9(11):1-17.
30. Jones-Hall YL, Skelton JM, Adams LG. Implementing Digital Pathology into Veterinary Academics and Research. J Vet Med Educ 2021;49(5):547-555.
31. Kim YJ, Roh EH, Park S. A literature review of quality, costs, process-associated with digital pathology. J Exerc Rehabil 2021;17(1):11-14.
32. Klaver E, van der Wel M, Duits L, et al. Performance of gastrointestinal pathologists within a national digital review panel for Barrett’s oesophagus in the Netherlands: results of 80 prospective biopsy reviews. J Clin Pathol 2021;74(1):48-52.
33. Korzynska A, Roszkowiak L, Zak J, et al. A review of current systems for annotation of cell and tissue images in digital pathology. Biocybern Biomed Eng. 2021;41(4):1436-1453.
34. Kumar N, Gupta R, Gupta S. Whole Slide Imaging (WSI) in Pathology: Current Perspectives and Future Directions. J Digit Imaging 2020;33(4):1034-1040.
35. Laurent-Bellue A, Redon MJ, Posseme K, et al. Four-Year Experience of Digital Slide Telepathology for Intraoperative Frozen Section Consultations in a Two-Site French Academic Department of Pathology. Am J Clin Pathol 2020;154(3):414-423.
36. Limperio V, Brambilla V, Cazzaniga G, et al. Digital pathology for the routine diagnosis of renal diseases: a standard model. J Nephrol 2021;34(3):681-688.
37. Parwani AV. Next generation diagnostic pathology: use of digital pathology and artificial intelligence tools to augment a pathological diagnosis. Diagn Pathol 2019;14(1):138.
38. Post RS, van der Laak JAWM, van der Sturm B, et al. The evaluation of colon biopsies using virtual microscopy is reliable. Histopathology 2013;63:114.
39. Rajaganesan S, Kumar R, Rao V, et al. Comparative Assessment of Digital Pathology Systems for Primary Diagnosis. J Pathol Inf 2021;12(1):1-15.
40. Retamero JA, Aneiros-Fernandez, J., del Moral, R. G. . Complete Digital Pathology for Routine Histopathology Diagnosis in a Multicenter Hospital Network. Arch Pathol Lab Med 2020;144(2):221-228.
41. Retamero JA, Aneiros-Fernandez J, Del Moral RG. Microscope? No, thanks: User experience with complete digital pathology for routine diagnosis. Arch Pathol Lab Med 2020;144(6):672-673.
42. Schumacher VL, Aeffner F, Barale-Thomas E, et al. The Application, Challenges, and Advancement Toward Regulatory Acceptance of Digital Toxicologic Pathology: Results of the 7th ESTP International Expert Workshop (September 20-21, 2019). Toxicol Pathol 2021;49(4):720-737.
43. Stathonikos N, Veta M, Huisman A, et al. Going fully digital: Perspective of a Dutch academic pathology lab. Journal of pathology informatics 2013;4(1):15.
44. Stathonikos N, Nguyen TQ, Spoto CP, et al. Being fully digital: perspective of a Dutch academic pathology laboratory. Histopathology 2019;75(5):621-635.
45. Stathonikos N, ,, Van Varsseveld NC, Vink A, et al. Digital pathology in the time of corona. J Clin Pathol 2020;73(11):706-712.
46. Unternaehrer J, Zlobec I, Grobholz R, et al. Current opinion, status and future development of digital pathology in Switzerland. J Clin Pathol 2020;73(6):341-346.
47. Veta M, van Diest PJ, Willems SM, et al. Assessment of algorithms for mitosis detection in breast cancer histopathology images. Medical Image Analysis 2015;20(1):237-248.
48. Vodovnik A, Riste T, Sund BS. Digital Pathology During a Pandemic. J Pathol Inform 2020;11:1-2.
49. Williams B, Hanby A, MillicanSlater R, et al. Digital pathology for primary diagnosis of screendetected breast lesions – experimental data, validation and experience from four centres. Histopathology 2020;76(7):968-975.
50. Williams BJ, Treanor D. Practical guide to training and validation for primary diagnosis with digital pathology. J Clin Pathol 2020;73(7):418-422.
51. Zarella MD, Bowman D, Aeffner F, et al. A Practical Guide to Whole Slide Imaging: A White Paper From the Digital Pathology Association. Arch Pathol Lab Med 2019;143(2):222-234.

Since 1985 Prof Dr. Ruitenberg developed 4-years curriculum in order to harmonize international education requirements, recognition and registration of this profession. The commission registration laboratory animal pathologists was then established. In 1990 this initiative was further expanded by Prof. Dr. J Vos in 1990 in cooperation with the former committee members. Currently the education has two directions, with the final purpose registration as laboratory Animal Pathologist (consider pathology reseach in animal models of human deseases), or Toxicologic Pathologist. The education curriculum for Toxicologic Pathologists is internationally considered to be one of the better educations for the profession (Version Curriculum1996: “Regulations on Education and Registration/Training programme, Committee for the registration of laboratory Animal/Toxicological Pathologists (CRP/TP) in The Netherlands”).

Currently, every 5 years the Committee for the registration of laboratory Animal/Toxicological Pathologists (CRP/TP) checks the registration status of all Board Certified Pathologists for re-registration. Re-registration will occur every 5 years and will be approved if the Toxicologic Pathologist has remained active in the field during these 5 years. Requirements for approval besides the daily activities within the field (can also include management activity in the pathology field) are courses, post-academic education, slide seminars, congresses and other meetings, publications or presentations.

Dr. R.J.M.M. Thoolen was Board Certified since 1993. On June 15^th, 2022 he received his re-registration as Toxicologic Pathologist for the next 5 years.

Ukraine is under attack just to feed “the Ego” of some. It is time that they gain insight into the “non-sense” of war. In this turmoil, Global Pathology Support (GPS) is ploughing on to guard the safety of vaccines, medicines, and chemicals. We just finished full read evaluations of two large projects on carcinogenicity (OECD 453) and histopathology and neuropathology evaluations of one extended one generation toxicity/neurotoxicity study (OECD 443).

A chapter on liver, gallbladder, and pancreas for CRC Press/Francis-Taylor Publishers to publish in a book titled “Toxicologic Pathology: An Atlas “has been finished recently and which will be published in 2022.

GPS is also considering applying Digital Pathology, as recent developments in this area has opened doors, for not only peer review or educational pathology, but also for routine histopathology evaluations. Many publications have shown reliable assessment for different organs systems as compared to conventional (toxicologic) pathology. At the same time pragmatic gain has been established over the years in the speed, logistics and resolution of images generated by digital scanning. Many good systems are on the market like: Hamamatsu, 3DHistech, Aperio (Leica), Sectra and last but not least Phillips. Quality, inter-activity and flexibility are paramount for GPS for the use of such system as it has to match the conventional pathology assessment as close as possible in every aspect and meet the GLP-guidelines.

Other services by GPS to our clients that has already been implemented, is the histology preparation of slides from wet tissues in combination with histopathology evaluation.

Keeping up the good spirit for everyone around the world for a better and safer world, GPS keeps on contributing to our clients in the best possible ways in order to produce safe vaccines, pharmaceuticals and chemicals on a global scale.

For more information call +31 70 3142404.

Kind regards,
Dr. Bob

Following the announcement of 02 September, 2021, I am pleased to announce that we have again gained our new GLP-Compliance from the Dutch Authorities.